Glaukos Share Holder Equity 2014-2025 | GKOS
Glaukos share holder equity from 2014 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Glaukos share holder equity for the quarter ending September 30, 2025 was $0.770B, a 15.11% increase year-over-year.
- Glaukos share holder equity for 2024 was $0.767B, a 66.09% increase from 2023.
- Glaukos share holder equity for 2023 was $0.462B, a 12.88% decline from 2022.
- Glaukos share holder equity for 2022 was $0.53B, a 9.73% decline from 2021.
|
Glaukos Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $767 |
| 2023 | $462 |
| 2022 | $530 |
| 2021 | $587 |
| 2020 | $667 |
| 2019 | $673 |
| 2018 | $174 |
| 2017 | $138 |
| 2016 | $117 |
| 2015 | $95 |
| 2014 | $-4 |
| 2013 | $7 |
|
Glaukos Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $770 |
| 2025-06-30 | $765 |
| 2025-03-31 | $764 |
| 2024-12-31 | $767 |
| 2024-09-30 | $669 |
| 2024-06-30 | $665 |
| 2024-03-31 | $451 |
| 2023-12-31 | $462 |
| 2023-09-30 | $478 |
| 2023-06-30 | $489 |
| 2023-03-31 | $509 |
| 2022-12-31 | $530 |
| 2022-09-30 | $549 |
| 2022-06-30 | $562 |
| 2022-03-31 | $598 |
| 2021-12-31 | $587 |
| 2021-09-30 | $601 |
| 2021-06-30 | $584 |
| 2021-03-31 | $590 |
| 2020-12-31 | $667 |
| 2020-09-30 | $662 |
| 2020-06-30 | $662 |
| 2020-03-31 | $641 |
| 2019-12-31 | $673 |
| 2019-09-30 | $190 |
| 2019-06-30 | $188 |
| 2019-03-31 | $185 |
| 2018-12-31 | $174 |
| 2018-09-30 | $163 |
| 2018-06-30 | $149 |
| 2018-03-31 | $143 |
| 2017-12-31 | $138 |
| 2017-09-30 | $132 |
| 2017-06-30 | $126 |
| 2017-03-31 | $123 |
| 2016-12-31 | $117 |
| 2016-09-30 | $110 |
| 2016-06-30 | $105 |
| 2016-03-31 | $98 |
| 2015-12-31 | $95 |
| 2015-09-30 | $95 |
| 2015-06-30 | $95 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-4 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.131B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $239.063B | 28.41 |
| Intuitive Surgical (ISRG) | United States | $187.731B | 73.45 |
| IDEXX Laboratories (IDXX) | United States | $55.613B | 55.23 |
| Edwards Lifesciences (EW) | United States | $49.407B | 33.13 |
| IQVIA Holdings (IQV) | United States | $41.110B | 22.92 |
| Alcon (ALC) | Switzerland | $40.371B | 27.21 |
| Mettler-Toledo (MTD) | United States | $29.477B | 34.49 |
| DexCom (DXCM) | United States | $28.124B | 38.77 |
| STERIS (STE) | Ireland | $25.634B | 26.46 |
| Waters (WAT) | United States | $23.623B | 31.24 |
| Coloplast (CLPBY) | Denmark | $19.267B | 32.88 |
| Hologic (HOLX) | United States | $16.749B | 17.60 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.665B | 0.00 |
| Penumbra (PEN) | United States | $14.008B | 98.53 |
| Globus Medical (GMED) | United States | $12.601B | 26.45 |
| Masimo (MASI) | United States | $7.854B | 25.17 |
| Sysmex ADR (SSMXY) | Japan | $6.163B | 19.58 |
| TransMedics (TMDX) | United States | $4.573B | 54.17 |
| Teleflex (TFX) | United States | $4.550B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.455B | 18.66 |
| Veracyte (VCYT) | United States | $3.423B | 39.01 |
| Integer Holdings (ITGR) | United States | $3.048B | 14.31 |
| Alphatec Holdings (ATEC) | United States | $2.530B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.422B | 22.66 |
| Artivion (AORT) | United States | $2.099B | 96.33 |
| UFP Technologies (UFPT) | United States | $2.045B | 27.00 |
| Nihon Kohden (NHNKY) | Japan | $1.953B | 17.05 |
| PROCEPT BioRobotics (PRCT) | United States | $1.729B | 0.00 |
| AxoGen (AXGN) | United States | $1.523B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.406B | 0.00 |
| IRadimed (IRMD) | United States | $1.313B | 62.56 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.973B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.950B | 5.14 |
| SiBone (SIBN) | United States | $0.737B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.731B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.725B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.681B | 39.62 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.597B | 11.91 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.550B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.477B | 13.18 |
| OrthoPediatrics (KIDS) | United States | $0.467B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.436B | 0.00 |
| RxSight (RXST) | United States | $0.409B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.398B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.365B | 60.82 |
| Sight Sciences (SGHT) | United States | $0.337B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.250B | 0.00 |
| 908 Devices (MASS) | United States | $0.244B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.204B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.197B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.158B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.156B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Solana (HSDT) | United States | $0.125B | 0.00 |
| Hyperfine (HYPR) | United States | $0.124B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.118B | 0.00 |
| Accuray (ARAY) | United States | $0.092B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.072B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.42 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |